Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03436771 · ClinicalTrials.gov registry record
Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product
A clinical trial, sponsored by Juno Therapeutics, a Subsidiary of Celgene.
- Terminated
- Registry status
- 4
- Enrollment target
NCT03436771 is a clinical trial that was terminated before completion, run by Juno Therapeutics, a Subsidiary of Celgene. The registered enrollment target is 4 participants.
The verdict
NCT03436771 was terminated before completion, sponsored by Juno Therapeutics, a Subsidiary of Celgene.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
This study will provide long-term follow-up for patients who have received treatment with a Juno CAR T-cell product in a Juno-sponsored clinical trial. In this study, patients will be followed for up to 15 years after their last dose of Juno CAR T cells for evaluation of delayed adverse events, presence of persisting CAR T-cell vector sequences, presence of replication-competent retrovirus (RCR) or lentivirus (RCL), and survival.
Interventions
- GENETIC JCAR017
- GENETIC JCARH125
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2018-02-19 |
| Est. Completion | 2018-07-20 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03436771
The ClinicalTrials.gov registry entry for NCT03436771 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Juno Therapeutics, a Subsidiary of Celgene, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which JCAR017 is the first listed.
NCT03436771 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03436771 about?
NCT03436771 is a clinical study titled "Long-term Follow-up Study for Patients Previously Treated With a Juno CAR T-Cell Product". This study will provide long-term follow-up for patients who have received treatment with a Juno CAR T-cell product in a Juno-sponsored clinical trial. In this study, patients will be followed for up to 15 years after their last dose of Juno CAR T cells for evaluation of delayed adverse events, pres...
What is the current status of trial NCT03436771?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2018-02-19. Estimated completion is 2018-07-20.
What interventions are being tested in trial NCT03436771?
The interventions under investigation include: JCAR017 (GENETIC), JCARH125 (GENETIC).
Who is sponsoring clinical trial NCT03436771?
This trial is sponsored by Juno Therapeutics, a Subsidiary of Celgene, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.